Covista Inc.
CVSAConsumer DefensiveNASDAQEducation & Training Services
Scan Results
Daily timeframeCovista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. At a $4.46B market cap, Covista Inc. ranks as a mid-cap company within consumer defensive.
Market Cap
$4.46B
Beta
0.65
P/E (TTM)
17.60
P/E (Fwd)
13.18
EPS (TTM)
$7.49
EPS (Fwd)
$10.01
ROE
18.6%
ROA
8.5%
Cash
$406.3M
Total Debt
$905.5M
Free CF
$323.9M
52W Change
-13.8%
Annual Financials
Cash vs Debt
Where CVSA stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, CVSA finished 4.30% above its 150-day moving average ($123.28) and 8.13% above its 200-day moving average ($118.91). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CVSA overbought or oversold?
At the October 20, 2026 close, CVSA's RSI(14) was 75.7, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $406.3M in cash, though total debt stands at $905.5M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $323.9M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 18.6% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 8.5% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $1.45B (2023) to $1.95B (2026), reflecting a 35% increase over the period.
CVSA's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing CVSA.